Literature DB >> 5041348

[Therapy of parkinsonian syndromes and plasmatic DOPA levels. Effects of L-DOPA and 3-OMD, administered alone or combined, with or without a decarboxylase inhibitor].

F Geissbühler, J M Gaillard, J J Eisenring, M Krassoievitch, G Yanniotis, R Tissot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5041348

Source DB:  PubMed          Journal:  Rev Eur Etud Clin Biol        ISSN： 0035-3019


× No keyword cloud information.
  1 in total

1.  Demethylation of L-3-methoxytyrosine in vivo.

Authors:  G Bartholini; A Pletscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.